Submit Deal

ERYTECH

Summary

ERYTECH Pharma, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 35 M

Avg. Deal Size£ 35 M

Market Context

Senior Management

Gil Beyen
Chief Executive Officer
Eric Soyer
CFO & COO

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy